The Latest Cardiac and Vascular News
– INXN-4001 delivered via retrograde coronary sinus infusion was well-tolerated in patients with chronic heart failure – – Preliminary data suggest an overall improvement in patient reported outcomes in 50% of patients six months after treatment – GERMANTOWN, Md., Aug. 6, 2020 /PRNewswire/ — Precigen Triple-Gene, a clinical stage cardiovascular gene therapy company […]
New awareness campaign empowers patients to proactively manage treatment decisions as fears of hospital visits increase during COVID-19 TORRANCE, Calif., Aug. 5, 2020 /PRNewswire/ — A national survey released today by patient advocacy group Heart-Valve-Surgery.com with support by Medtronic, found that nearly half (49 percent) of heart valve patients say return to active […]
New data from INSPIRE LIQ861 safety and tolerability study in pulmonary arterial hypertension (PAH) patients demonstrate positive trends in exploratory endpoints, including quality of life (QoL) RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development […]
DANVERS, Mass.–(BUSINESS WIRE)–The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading and support to COVID-19 patients who are undergoing ECMO treatment and develop pulmonary edema or myocarditis. Impella is manufactured by Abiomed (NASDAQ: ABMD). COVID-19 causes widespread inflammation which can […]
Amarin to Build Dedicated Organization to Retain Substantial Value of One of the Most Anticipated Cardiovascular Drug Products in Decades Veteran Cardiovascular Commercial Executive Hired to Lead Focused Launch DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), today announced the company’s plans to undertake […]
COVID-19 Preclinical Work Continues CALGARY, Alberta, Aug. 04, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) is pleased to announce today the recent publication of an article titled: “Epigenetic modulation by apabetalone counters cytokine driven acute phase response in vitro, in mice and in patients with cardiovascular disease”, in […]
The software significantly improves workflows for analysis, increasing efficiency and reducing costs REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k) clearance from the FDA for its Bioflux Software II System. The software […]
Largest Private Cardiology Practice in Virginia Expanded Offerings Using Telehealth During COVID-19 IRVINE, Calif.–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that Virginia Cardiovascular Specialists (VCS), the largest private cardiology practice in Central Virginia, implemented NextGen Virtual Visits™ to expand care and treatment to patients for […]
VALOR-HCM Designed to Generate Direct Evidence of Improved Outcomes for People with HCM by Reducing the Need for Invasive Septal Reduction Therapy BRISBANE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline on Monday, August 3rd by MyoKardia, Inc. (Nasdaq: MYOK), please note that the second quote by Jeffrey B. […]
BOZEMAN, Mont., July 31, 2020 /PRNewswire/ — Pulsara, the leading telehealth and communication platform that connects teams across organizations, announced today that the company has been named a compatible vendor within the American Heart Association Get With The Guidelines® program. This premier AHA program assists hospitals in measuring and improving cardiovascular disease and […]
